About this Event
Join us for CA-START San Diego's July 2024 CET: The Weight Behind The Prescription: Metabolic Effects of Psychotropic Medic*tion in Autism. This event -- facilitated by Wajdi Akef Fakhoury (Clinical Director) and Ingrid Dombrower, MD (Medical Director) -- is designed to shed light on the complex relationship between metabolic syndrome and the use of psychotropic medications for managing irritability in individuals with Autism Spectrum Disorder (ASD). Our goal is to provide comprehensive knowledge and practical strategies to support the biopsychosocial health of individuals navigating IDD -- including Autism.
Event Highlights:
Case Study Focus: The presentation will center around a de-identified START client case study, providing real-world context and illustrating the challenges and solutions in managing metabolic syndrome within this population. This case will help ground our discussion and demonstrate the practical application of the strategies discussed.
Community Engagement:
A significant portion of the meeting will be dedicated to eliciting recommendations and insights from our attendees -- our community of experts! This collaborative approach aims to enhance our collective understanding and develop best practices for supporting individuals enrolled at START.
Conclusion:
By attending this presentation, participants will leave with a comprehensive understanding of the metabolic effects of psychotropic medications in autism, equipped with practical strategies for advocacy and management, and inspired to collaborate in supporting the health and wellness of individuals enrolled at CA-START San Diego. Don't miss this opportunity to join a community of experts in promoting overall well-being in the care of individuals navigating Autism.
Join us for a deep dive into this critical topic and contribute to a collaborative effort in advancing both metabolic and mental health care in the autism community.
Understanding Metabolic Syndrome:
- Gain a clear understanding of what metabolic syndrome entails, including its key components such as obesity, insulin resistance, hyperlipidemia, and hypertension.
- Explore how psychotropic medications commonly prescribed to manage irritability in autism can contribute to the development of metabolic syndrome.
Weighing Risks and Benefits:
- Analyze the potential risks and benefits associated with the use of psychotropic medications that may increase the risk of metabolic syndrome.
Monitoring and Managing Metabolic Syndrome:
- Explore practical home-based methods for managing and monitoring metabolic health, such as regular weight checks, blood sugar monitoring, and dietary adjustments.
- Explore how to engage individuals navigating ASD in these activities by leveraging their interests and strengths.
- Emphasize the role of a coordinated care system that promotes both metabolic and mental health through consistent monitoring and lifestyle interventions.
-----------------------------------------
We are excited to announce that this CET will be a hybrid event, offering both in-person and online participation. Tuesday, 07/30/2024 (3-4:30pm).
In-person: 3870 Murphy Canyon Road, Suite 150 San Diego, CA 92123
Remote Access: Please use the following link:
- Join Zoom Meeting
https://us02web.zoom.us/j/84057285623?pwd=WWpHaWpXV21zRlZaczVUK0c4SEJRUT09 - Meeting ID: 840 5728 5623
Passcode: 738031
Event Venue & Nearby Stays
3870 Murphy Canyon Rd suite 150, 3870 Murphy Canyon Road, San Diego, United States
USD 0.00